Table 2. Hazard ratios (HR) and 95% confidence intervals (CI) for pancreatic cancer risk according to category of BMI at baseline among males.
Categories of BMI at baseline (kg/m2) | Trend (per 1 kg/m2) |
Trend P | Heterogeneity [P, I2 (%)] | ||||||||
<19 | 19 to <21 | 21 to <23 | 23 to <25 | 25 to <27 | 27 to <30 | ≥30 | For trend | For the highest category | |||
Number of subjects (N) | 10,043 | 27,472 | 42,006 | 39,963 | 22,006 | 10,754 | 2,672 | ||||
Person-years (N) | 111,259.9 | 345,620.1 | 544,890.7 | 532,025.8 | 295,509.3 | 145,176.7 | 34,168.7 | ||||
Number of cases (N) | 70 | 183 | 234 | 199 | 95 | 50 | 18 | ||||
Crude rate (per 100,000) | 62.9157 | 52.9483 | 42.9444 | 37.4042 | 32.1479 | 34.4408 | 52.6798 | ||||
HR (model 1) overall | 1.24 (0.85–1.81) | 1.26 (0.98–1.63) | 1.08 (0.90–1.31) | Reference | 0.91 (0.71–1.17) | 1.11 (0.81–1.53) | 1.73 (1.04–2.87) | 0.97 (0.94–1.01) | 0.112 | P = 0.065, 45.7 | P = 0.890, 0 |
HR (model 2) overall | 1.22 (0.85–1.77) | 1.26 (0.98–1.63) | 1.08 (0.89–1.31) | Reference | 0.91 (0.71–1.17) | 1.12 (0.82–1.54) | 1.71 (1.03–2.86) | 0.97 (0.94–1.01) | 0.113 | P = 0.094, 41.0 | P = 0.931, 0 |
HR (model 1) excluding early cases |
1.14 (0.73–1.79) | 1.22 (0.92–1.62) | 1.00 (0.81–1.22) | Reference | 0.87 (0.66–1.16) | 1.00 (0.69–1.45) | 1.66 (0.96–2.89) | 0.97 (0.93–1.01) | 0.106 | P = 0.075, 44.0 | P = 0.908, 0 |
HR (model 2) excluding early cases |
1.14 (0.73–1.78) | 1.22 (0.92–1.62) | 1.00 (0.82–1.23) | Reference | 0.87 (0.65–1.17) | 1.01 (0.71–1.45) | 1.65 (0.94–2.88) | 0.97 (0.93–1.01) | 0.090 | P = 0.122, 37.1 | P = 0.941, 0 |
BMI, body mass index.
Model 1 adjusted for age and area (within each study for JPHC and JACC). Model 2 adjusted for age, area, smoking (pack-years [PY] = 0, 0 < PY ≤ 20, >20, or unknown), drinking (never, <1 week/day, current <23 g/day, 23 to <46 g/day, 46 to <69 g/day, ≥69 g/day, or unknown), and history of diabetes (yes, no, or unknown). HRs values in bold show statistical significance.